Background and Objectives: Bone marrow derived mesenchymal stem cells (BM-MSCs) have been proposed as effective treatment of many diseases owing to their unique ability to differentiate into other cell types in vivo. Schistosoma mansoni (S. mansoni) infection is characterized by hepatic granuloma formation around schistosome eggs at acute stage of infection, followed by hepatic fibrosis at chronic and advanced stages. Whether BM-MSCs have an ameliorative effect on hepatic tissue injury caused by S. mansoni infection or not, was inspected in the current study. Materials and Results: Female Swiss Albino mice were divided into a control group and an experimental group. Half of control animals served as donors for bone marrow stem cells, and the other half was used to collect liver samples. Experimental group was injected with circariae of S. mansoni, and then subdivided into three subgroups; Subgroup B1, sacrificed after eight weeks of infection without treatment, subgroup B2, received BM-MSCs at the eighth week and sacrificed four weeks later, and subgroup B3, was untreated till the twelfth week of infection. Histological examination of liver samples showed the formation of granulomas and liver fibrosis which were extensive in subgroup B3. However, treated subgroup illustrated improvement of liver histology, signs of hepatocytes regeneration, and possible contribution of oval cell in the process of hepatic and biliary regeneration. Conclusion: BM-MSCs decreased liver fibrosis and contributed to an increase in oval cells, generation of new hepatocytes and/or to the improvement of resident hepatocytes in S. mansoni infected mice.
Introduction
Schistosomiasis is a widespread parasitic infective disease that remains endemic in many countries. Despite major advances in control and substantial decreases in morbidity and mortality, schistosomiasis continues to spread to new geographic areas (1) . One of the experimental models of hepatic fibrosis used to elucidate the mechanism involved in fibrogenic process is chronic infection with Schistosoma mansoni (S. mansoni) (2) . The most commonly used therapeutic drug is praziquantel (PZQ), which has demonstrated efficacy in both prevention of some types of schistosoma infection and substantial reduction of worm burden in infected patients (3) . Though, some reports established resistance to PZQ, the mainstay of medical treatment (4), besides, the hepatic fibrosis caused by schistosomiasis is not eliminated by PZQ and has remained a clinical challenge (5) . Hence, it is of great significance to explore new therapeutic approaches to ameliorate the damages caused by fibrogenesis in chronic liver disease (6) .
Mesenchymal stem cells (MSCs) have recently emerged as an effective advance to treat a variety of diseases with minimal invasive procedures and few complications (7) . MSCs are multipotent cells that are capable of differentiating into functional hepatocytes, which have been effective in regenerating liver structure and promoting recovery of liver function (8) . Thus, it is worthy to explore the possible role of MSCs in ameliorating liver damage caused by schistosomiasis.
Study design
50 Female Swiss Albino mice, 7 weeks old, weighing about 25 gm were housed at the Schistosome Biological Material Supply Center of Theodor Bilharz Research Institute (TBRI), Giza, Egypt and treated in accordance with the valid International Guidelines for animal experimentation. Animals were classified into group A (control group, n=20) and group B (experimental group, n=30). Animals in group A were equally subdivided into subgroup A1 (n=10) which served as donors for stem cells obtained from their bone marrow, and subgroup A2 (n=10) which were injected with phosphate buffer saline (PBS) and used to collect control liver samples. Whereas, animals in group B, were all infected with S. mansoni cercariae (60/mouse) (obtained from infected Biomphalaria alexandrina snails which were bred and maintained at the TBRI) injected subcautaneously, then subdivided into three subgroups; subgroup B1 (n=10) sacrificed after eight weeks, subgroup B2 (n=10) treated with 2×10 6 MSCs suspended in PBS per mouse at eighth week after infection then scarified four weeks later, and subgroup B3 (n=10) allowed to survive for twelve weeks without treatment then sacrificed.
Infection was assured by finding S. mansoni eggs in stool 42 days post infection.
Preparation and isolation of BM-MSCs for intraperitoneal administration
Bone marrow cells were harvested by flushing the tibiae and femurs of mice in subgroup A1 with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) -purchased from Lonza company, Swiss-, washed in PBS, resuspended in complete media supplemented with 1% penicillin-streptomycin, seeded in culture dishes, and incubated at 37 o C in 5% humidified CO2 for 2∼3 days or upon formation of large colonies. When large colonies developed (80∼90% confluence), cultures were washed twice with PBS and the cells were detached using 0.25% trypsin in 1 mM EDTA for 5 min at 37 o C. The suspension then centrifuged, viable and nonviable cells were counted using hemocytometer, followed by subculturing viable cells at 4×10 3 cells/cm 2 , and used for experiments after the third passage.
BM-MSCS in culture were characterized by their adhesiveness and fusiform shape (Fig. 1A and 1B) . Also, immune-histochemical detection of CD44 as a marker for BM-MSCS was done (Fig. 1C) . Further characterization was performed by incubating BM-MSCS in osteogenic media for 21 days and detection of mineralized matrix deposition using alizarin red stain (Fig. 1D) (9) .
Fluorescence labelling for In Vivo Tracking of BM-MSCs (10) BM-MSCs were labelled using the PKH26 red fluorescence cell linker kit (Sigma Aldrich, USA) according to the manufacturer's protocol. In brief, subconfluent MSC after the third passage were detached and washed three times with serum-free medium. Cells were re-suspended at 1×10 7 cells in 1 ml of diluent C plus dye, followed by incubation at 25 o C for 5 min. To stop the reaction, 2 ml of FBS was added. Cells were supplemented with 4 ml of complete medium and washed three times. Cells were resuspended at 1×10 6 cells in complete medium and used within 30 min. For assessment of vitality and preservation of differentiation capacity of PKH26-labeled MSCs, they were reseeded onto plates and then underwent differentiation testing upon reaching confluence. For testing viability of PKH26-labeled primary BM-MSCs, they were re-cultured. Fluorescent microscope examination of liver specimens of mice treated with the labeled cells (subgroup B2) was done to insure their incorporation into liver tissue (Fig. 6A ).
Histological and immune-histochemical studies
For light microscopic examination; liver samples were fixed in 10% buffered formalin, dehydrated, cleared and embedded in paraffin. Serial 5 μm sections of the right lobes of the livers were stained with hematoxylin and eosin (H&E), Masson's trichrome stain and immune-histochemical staining for cytokeratin 7 (CK7).
For transmission electron microscope (TEM) examination; small liver specimens (1 mm chrome stain, the circumference of granulomatous lesion and the mean number of CK7 positive cells were measured in randomly chosen five fields/ section in five sections for every rat in each group at magnification 400.
Statistical analysis
The measured parameters in the different subgroups were compared with each other using the statistical package for the social sciences (SPSS) computer program analysis for variance (ANOVA)-one way analysis and post-Hoc least significant difference (LSD). Differences were considered significant when the p value was ≤0.05. Summary of the data was expressed as mean±standard deviation (SD).
Results

Light microscope examination
Examination of H & E stained sections of the control group revealed intact classical hepatic lobules with plates of hepatocytes radiating from the central vein separated by blood sinusoids ( Fig. 2A) . In subgroup B1 (eight weeks after injection with circariae) few small bilharizial graulomas were seen around bilharizial ova, sparing part of the liver tissue inbetween them (Fig. 2B) . In subgroup B2 (treated group) the granulomatous lesions decreased both in number and size sparing wider areas of the liver tissue (Fig. 2C) , also, many small oval cells having oval nuclei and deeply stained cytoplasm were seen along the periphery of the granulomatous lesions (Fig. 3A) . In the same group, bile ducts appeared almost intact and were lined with columnar epithelium (Fig. 3C) . On the contrary, in the untreated group sacrificed 12 weeks after circariae injection (Subgroup B3); the granulomatous lesions were profuse and large, with only narrow liver tissue appear inbetween them (Fig. 2D) , oval cells were almost absent (Fig. 3B ) and bile ducts were distorted with vacuolated epithelium (Fig. 3D) .
In Masson's trichrome stained sections, few collagen fibers were observed in the control group around the central veins and portal areas (Fig. 4A) . In subgroup B1, an increase in the amount of collagen fibers was noted in the granulomatous lesions (Fig. 4B) , whereas in subgroup B2, the amount of collagen fibers in the graulomatous lesions were markedly decreased (Fig. 4C) . In subgroup B3, the granulomatous lesions were almost replaced with collagen fibers with bridging fibrosis between them occupying most of the liver tissue (Fig. 4D) .
Liver sections immunohistochemically stained for CK7; showed few CK7 positive cells lining the bile ducts and around them in the control group (Fig. 5A) . In subgroup B1, only very few CK7 positive cells were detected along the periphery of the granulomatous lesions (Fig. 5B) , in contrast, CK7 positive cells were very numerous around the granulomatous lesions in subgroup B2 (Fig, 5C ). In the untreated group (subgroup B3) the CK7 positive cells were few (Fig. 5D ).
Electron microscopic examination
Ultra-thin sections of liver specimens of the control group showed that hepatocytes had large rounded, central vesicular nucleus with the usual characteristic chromatin distribution. The cytoplasm illustrated numerous mitochondria, rough endoplasmic reticulum (rER), and gly- cogen rosettes (Fig. 6B) . Moreover, few microvilli of the hepatocytes were projecting into the space of Disse, hepatocytes stellate cells (HSCs) were seen in the perisinusoidal space with many fat droplets in their cytoplasm and bile canaliculi appeared with microvilli projecting into them (Fig. 6C) . In subgroup B1, hepatocytes were necrotic, their nuclei showed abnormal chromatin distribution, the bile canaliculi illustrated partial loss of microvilli, and an increase in the amount of collagen fibers was noticed. Eosinophils appeared in the blood sinusoids with their characteristic granules (Fig. 6D) . Hepatocytes in Subgroup B2 were premature with signs of regeneration in the form of irregular nuclear membrane and an increase of organelles e.g. mitochondria, rER and free ribosomes (Fig. 7A) . Microvilli that project in the space of Disse and in bile canaliculi were almost as in the control group (Fig. 7B) . In subgroup B3, collagen fibers were abundant and HSCs were detected in the perisinusoidal space, also, hepatocytes showed features of necrosis, and bile canaliculi illustrated partial loss of microvilli (Fig.  7C&D) .
Morphometric & statistical results
The highest peaks of collagen area percentage were measured in untreated mice (subgroups B1 and B3). There was a significant reduction in the area percentage in control animals and in subgroup B2 as compared to those in subgroups B1 and B3 (p=0.000 and p=0.000), although subgroup B2 recorded a significant increase (p=0.018) as compared to that in control mice ( Table 1) .
The mean number of CK7 positive cells / HPFs reached its highest peaks and showed a significant increase in treated rats that received BM-MSCs (subgroup B2) when compared to control group, subgroups B1 & subgroup B3. On the other hand, a non-significant difference (p=0.648) was measured in subgroup B1 as compared to that in sub- group B3 (Table 1) .
The mean granuloma circumference reached its highest peaks in subgroup B3 and measured a significant increase (p=0.000) as compared to subgroups B1 and B2. On the other hand, treated subgroup B2, measured the least circumference and a significant decrease (p=0.000) in the granuloma circumference was determined as compared to the other experimental untreated subgroups B1 and B3 (Table 1) .
Discussion
Schistosomiasis is one of the most widespread parasitic infestations. The main pathology in S. mansoni infection is the formation of granulomas around eggs trapped in the portal venules of liver tissue (11) . The eggs release a variety of substances that lead to antigen -specific humoral and cell mediated immune responses (12) which terminates in fibrosis and portal hypertension (13) .
The notion that injured tissues secrete chemotactic factors to recruit MSCs and the numbers of MSCs homing to the liver is independent of the route of infusion (14), supported our conception of the beneficial role of MSCs as a therapy to recover organ structure. Thus, the aim of the present study was to assess the ameliorative potential of MSCs in S. mansoni induced liver damage.
Ghanem et al. (13) , demonstrated that fibrosis developed during the chronic phase of granulomatous inflammation in murine schistosomiasis represent a protective function by isolating egg antigens that can potentially damage host tissues. In our study, the extent of fibrosis was estimated by the quantitative morphometric analysis of the collagen content in Masson's trichrome stained liver sections and granuloma area. The results re- vealed significant decrease in the collagen content after treatment with BM-MSCs.
One of the main mediators involved on fibrosis deposition during hepatic injury is transforming growth factor β (TGF-β) (15) . This cytokine stimulates the transition of stellate cells to myofibroblasts, which secrete high amounts of extracellular matrix and inhibit its degradation (16) . TGF-β levels were lowered after BM-MSC therapy in livers of S. mansoni-infected mice, reaching levels close to those found in normal mice (2) . A decrease in TGF-β production was also observed by Fang et al. (17) , after therapy using BM-MSCs in mice with liver injury caused by CCl4 administration.
On the other hand, Rygiel et al. (18) , reported that liver fibrosis is mainly due to accumulation of myofibroblasts, which may result from activation and proliferation of resident epithelial cells, including hepatocytes and bile duct cells, via epithelial-mesenchymal transition. In the current work; the decrease in liver fibrosis after treatment with BM-MSCs could be explained by the inactivation of HSCs by BM-MSCs, which is consistent with Pulavendran et al. (19) , findings which indicated that BM-MSCs can inhibit the activation of HSCs and induce apoptosis to relieve fibrosis. On the contrary, El-Mahdi et al. (20) , stated that the anti-fibrotic effect of BM-MSCs may be related to an enhancement of collagen degradation rather than a decrease in collagen synthesis.
Liver stem cells, termed oval cells in rodents (21) proliferate under certain pathological conditions, when hepatocyte proliferation is prevented by severe liver injury (22) . Oval cells, named for their morphological appearance, are bipotent precursor cells that can differentiate into bile duct cells (23) and hepatocytes (24) . Oval cells originate from the terminal branches of the intrahepatic biliary system, the canals of Hering (25) or next to bile ducts (26) . Hepatic oval cells and cholangiocytes but not normal hepatocytes express CK7 (27) .
In the present study, many small young oval cells exhibiting small oval shaped centrally located nuclei were present along the periphery of the granulomatous lesions confirmed by immune-histochemical staining for CK7 in MSCs treated subgroup. Also, marked proliferation of bile ductules, and signs of mature hepatocytes regeneration were detected in electron microscopic specimens in the same subgroup. These findings were not detected in the untreated subgroup.
All these previous findings strongly suggest the valuable role of MSCs in liver remodeling following Schistosomiasis induced liver damage. However, the sources of parechymal regeneration after hepatocellular liver injury still a matter of debate. Oliveira et al. (2) , explained that oval cells can be either originated from BM-MSCs, or it is possible that oval cells increase in the replacement areas where fibrosis degradation occurs with functional parenchymatous cells after BM-MSC therapy. Moreover, Petersen et al. (22) , put emphasis on the possibility that bone marrow may act, under certain physio-pathological conditions, as the progenitor of several types of liver cells. On the contrary, Vig et al. (28) , stated that the contribution to liver regeneration from BM-derived cells was small, and liver regeneration occurs mainly through resident oval cells. Also, Elkhafif et al. (29) , suggested that BM-MSCs may transdifferentiate into inflammatory cells, surrounding the granuloma, rather than into hepatic progenitor cells, presumably contributing to the host's reaction to the schistosomiasis infection. However, the exact characterization of this dif- ferentiation remains to be carried out using panels of antibodies against several specific markers in a more extensive study.
Conclusion
In conclusion, our study showed that transplantation of BM-MSCs in mice with chronic liver disease caused by S. mansoni infection decreased liver fibrosis and contributed to an increase in oval cells as well as to the generation of new hepatocytes and/or to the improvement of resident hepatocytes.
Although there are still many unanswered questions regarding the mechanisms of action of transplanted cells in hepatic lesions in relation to the type and extent of liver injury, the timing of cell administration and the threshold number of transplanted cells are all important variables in the process of engraftment and differentiation that still need to be further defined.
Recommendations
Long-term experiments are recommended to allow an extensive follow-up of the engrafted cells to define their proper role and fate within the animal livers in different types of liver injury before future transplantation approaches can be successfully applied to the clinical application.
